Top Markets
Coin of the day
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
Rankning i aktier #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
Aktiekurs
$0.38207938
Senast synkroniserad: 2025-04-07
Marknadsvärde
$1.67M
Förändring (1 dag)
-0.39%
Förändring (1 år)
0.00%
Land
FR
Handel Medesis Pharma S.A. (ALMDP)

Kategori

Aktiekurshistorik för Medesis Pharma S.A. (ALMDP)
Högsta slutkurs: $0.38 den 2025-04-01

Lägsta slutkurs: $15.89 den 2021-02-01
Aktiekurshistorik för Medesis Pharma S.A. från 2021 till 2026
Årlig aktiekursutveckling
År Prestanda
2025 7.86%
2024 -63.03%
2023 -54.06%
2022 -64.90%
2021 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE